Averica Discovery,
a Neopharm Labs Company
We are an analytical development contract research organization (CRO) with specialized expertise in small molecule analysis and purification. We work with pharmaceutical development teams to shorten timelines in the R&D process. Since our founding in 2007, we’ve developed a reputation for excellence, speed, and an ability to solve tough problems.
In 2016, Averica was acquired by Neopharm Labs. Based in the Montreal area, Neopharm has a 30+ year history of excellence in pharmaceutical testing and analysis. In combining the two companies, we’ve developed a fully integrated platform of services capable of taking your program from preclinical stage to commercial launch.
What we do
Averica and Neopharm are expanding operations in both Boston and Montreal. The two sites offer our clients both R&D and GMP analytical services, unique preparative and analytical chromatography services (including Averica’s well-known Supercritical Fluid Chromatography platform), and a cross-border consultative project management team capable of working with your candidate or product at any stage of development or production.